LONDON (AFX) - BioProgress PLC, the speciality pharmaceutical and healthcare company, said it will acquire Segix Farma, an Italian peer based near Rome, for 1.95 mln eur in a mixture of cash and shares.
BioProgress said the acquisition will be made through its newly-formed subsidiary Dexo BioPharm, with 700,000 eur paid in cash while the remainder will be made up of equity.
The company added that Segix generated revenue of 2.6 mln eur and made a profit of 200,000 eur in the year to December 31, 2005. newsdesk@afxnews.com wj COPYRIGHT Copyright AFX News Limited 2005. All rights reserved. The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News. AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
© 2006 AFX News
